Coexistence of a Novel NBAS-ALK, EML4-ALK Double-Fusion in a Lung Adenocarcinoma Patient With LM and Response to Ensartinib
文献类型:期刊论文
作者 | Xu, X.1,2,3; Li, N.3; Fan, Y.2,3 |
刊名 | JOURNAL OF THORACIC ONCOLOGY
![]() |
出版日期 | 2022-09-01 |
卷号 | 17 |
关键词 | ALK non-small cell lung cancer (NSCLC) leptomeningeal metastases (LM) |
ISSN号 | 1556-0864 |
WOS研究方向 | Oncology ; Respiratory System |
语种 | 英语 |
WOS记录号 | WOS:000858678101221 |
出版者 | ELSEVIER SCIENCE INC |
源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/129779] ![]() |
专题 | 中国科学院合肥物质科学研究院 |
作者单位 | 1.Zhejiang Chinese Med Univ, Hangzhou, Peoples R China 2.Chinese Acad Sci, Hangzhou, Peoples R China 3.Univ Chinese Acad Sci, Canc Hosp, Zhejiang Canc Hosp, Hangzhou, Peoples R China |
推荐引用方式 GB/T 7714 | Xu, X.,Li, N.,Fan, Y.. Coexistence of a Novel NBAS-ALK, EML4-ALK Double-Fusion in a Lung Adenocarcinoma Patient With LM and Response to Ensartinib[J]. JOURNAL OF THORACIC ONCOLOGY,2022,17. |
APA | Xu, X.,Li, N.,&Fan, Y..(2022).Coexistence of a Novel NBAS-ALK, EML4-ALK Double-Fusion in a Lung Adenocarcinoma Patient With LM and Response to Ensartinib.JOURNAL OF THORACIC ONCOLOGY,17. |
MLA | Xu, X.,et al."Coexistence of a Novel NBAS-ALK, EML4-ALK Double-Fusion in a Lung Adenocarcinoma Patient With LM and Response to Ensartinib".JOURNAL OF THORACIC ONCOLOGY 17(2022). |
入库方式: OAI收割
来源:合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。